Literature DB >> 21063125

Predictors of timing and patterns of recurrence after curative resection for gastric cancer.

Bang Wool Eom1, Hongman Yoon, Keun Won Ryu, Jun Ho Lee, Soo Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Il Ju Choi, Jong Seok Lee, Myung Cherl Kook, Sook Ryun Park, Byung-Ho Nam, Young-Woo Kim.   

Abstract

AIMS: The aim of the study was to characterize recurrence patterns and identify predictors of recurrence after curative resection.
METHODS: Of 2,786 patients that underwent curative resection for gastric cancer from 2001 to 2006 at the Korean National Cancer Center, 439 (15.8%) experienced recurrence. Patterns of recurrence, clinicopathological characteristics, and therapeutic modalities were compared between 251 patients who had recurrence within 1 year (the early recurrence group) and 188 patients who had recurrence after more than a year (the late recurrence group). Multivariate analysis was performed to identify independent factors associated with the timing of recurrence.
RESULTS: In the early recurrence group, the most common pattern was hematogenous metastasis, and in the late recurrence group, the most common pattern was locoregional and peritoneal recurrence. The early recurrence group was characterized by a larger tumor, frequent lymph node (LN) metastasis, and venous, and perineural invasion. Multivariate analysis showed that LN metastasis and venous invasion were independent predictors of early recurrence. Median survival after recurrence was significantly shorter in the early recurrence group (p < 0.001).
CONCLUSION: Hematogeneous metastasis was more common in the early recurrence group and LN metastasis and venous invasion were independent predictors of the timing of recurrence.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 21063125     DOI: 10.1159/000320691

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  25 in total

1.  A comparison of the effects of epidural analgesia versus traditional pain management on outcomes after gastric cancer resection: a population-based study.

Authors:  Kenneth C Cummings; Meatal Patel; Phyo Than Htoo; Paul M Bakaki; Linda C Cummings; Siran Koroukian
Journal:  Reg Anesth Pain Med       Date:  2014 May-Jun       Impact factor: 6.288

2.  Prognostic impact of microscopic tumor involved resection margin in advanced gastric cancer patients after gastric resection.

Authors:  Jung-Woo Woo; Keun Won Ryu; Ji Yeon Park; Bang Wool Eom; Mi Jung Kim; Hong Man Yoon; Sook Ryun Park; Myeong-Cherl Kook; Il Ju Choi; Young-Woo Kim; Young-Iee Park
Journal:  World J Surg       Date:  2014-02       Impact factor: 3.352

3.  Is it worthy of adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for distal gastric cancers with No. 6 lymph node metastasis?

Authors:  J Zhang; S Zou; R Luo; Z Zhu; Z Wang; H Xu; B Huang
Journal:  Clin Transl Oncol       Date:  2019-04-11       Impact factor: 3.405

4.  Safety and prognostic impact of prophylactic laparoscopic superior mesenteric vein (No. 14v) lymph node dissection for lower-third gastric cancer: a propensity score-matched case-control study.

Authors:  Qi-Yue Chen; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Chang-Ming Huang
Journal:  Surg Endosc       Date:  2017-09-15       Impact factor: 4.584

5.  Prognostic relevance of FGFR2 expression in stage II/III gastric cancer with curative resection and S-1 chemotherapy.

Authors:  Kei Hosoda; Keishi Yamashita; Hideki Ushiku; Akira Ema; Hiromitsu Moriya; Hiroaki Mieno; Marie Washio; Masahiko Watanabe
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

6.  Factors associated with recurrence within 2 years after curative surgery for gastric adenocarcinoma.

Authors:  Cheng-Yu Chiang; Kuo-Hung Huang; Wen-Liang Fang; Chew-Wun Wu; Jen-Hao Chen; Su-Shin Lo; Mao-Chih Hsieh; King-Han Shen; Anna Fen-Yau Li; Dau-Ming Niu; Shih-Hwa Chiou
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

7.  HER2 expression and its clinicopathological features in resectable gastric cancer.

Authors:  Yoshiki Kataoka; Hiroshi Okabe; Akihiko Yoshizawa; Sachiko Minamiguchi; Kenichi Yoshimura; Hironori Haga; Yoshiharu Sakai
Journal:  Gastric Cancer       Date:  2012-03-14       Impact factor: 7.370

8.  Factors associated with early recurrence after curative surgery for gastric cancer.

Authors:  Wei-Ming Kang; Qing-Bin Meng; Jian-Chun Yu; Zhi-Qiang Ma; Zhi-Tian Li
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

Review 9.  Exosome-mediated peritoneal dissemination in gastric cancer and its clinical applications.

Authors:  Kai-Bo Chen; Jian Chen; Xiao-Li Jin; Yi Huang; Qiu-Ming Su; Li Chen
Journal:  Biomed Rep       Date:  2018-04-19

10.  Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China.

Authors:  Liang Cao; Luke V Selby; Xiang Hu; Yi Zhang; Yelena Y Janjigian; Laura Tang; Daniel G Coit; Murray F Brennan; Vivian E Strong
Journal:  J Surg Oncol       Date:  2016-04-04       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.